Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)
Sponsors and Collaborators
M.D. Anderson Cancer Center
MD Anderson CCOP Network Sites
Michael Fisch, MD, MPH
Michael Fisch, MD,MPH
UT MD Anderson Cancer Center
Daniel J. Lenihan, MD
Vanderbilt University, Division of Cardiovascular Medicine
Next post in Genitourinary Cancer Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.